Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05161195
Title Roll-over Study to Allow Continued Access to Ribociclib
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | LBN | ITA | GRC | ESP | BRA | ARG

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers RECRUITING Chandler Arizona 85224 United States Details
Highlands Oncology Group RECRUITING Fayetteville Arkansas 72703 United States Details
Beverly Hills Cancer Center RECRUITING Beverly Hills California 90211 United States Details
Poudre Valley Hospital ACTIVE_NOT_RECRUITING Fort Collins Colorado 80528 United States Details
Mid Florida Hematology And Onc Ctr ACTIVE_NOT_RECRUITING Orange Florida 32763 United States Details
Summit Cancer Care ACTIVE_NOT_RECRUITING Savannah Georgia 31405 United States Details
John D Archbold Memorial Hospital ACTIVE_NOT_RECRUITING Thomasville Georgia 31792 United States Details
Duly Health and Care RECRUITING Plainfield Illinois 60585 United States Details
Indian Univ Health Goshen Center forCancer RECRUITING Goshen Indiana 46526 United States Details
Northern Light Mercy Hospital RECRUITING Portland Maine 04102 United States Details
Englewood Health RECRUITING Englewood New Jersey 07631 United States Details
The Valley Hospital-Luckow Pavillion RECRUITING Paramus New Jersey 07652 United States Details
Eastchester Center for Cancer Care COMPLETED Bronx New York 10469 United States Details
University Hospitals of Cleveland Seidman Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
Oklahoma Cancer Specialists and Research Institute RECRUITING Tulsa Oklahoma 74136 United States Details
Millennium Research Clin Develop ACTIVE_NOT_RECRUITING Houston Texas 77090 United States Details
Novartis Investigative Site RECRUITING San Juan J5402DIL Argentina Details
Novartis Investigative Site RECRUITING Natal RN 59075 740 Brazil Details
Novartis Investigative Site RECRUITING Ijui RS 98700-000 Brazil Details
Novartis Investigative Site RECRUITING Florianopolis SC 88034-000 Brazil Details
Novartis Investigative Site RECRUITING Sao Paulo SP 01317 000 Brazil Details
Novartis Investigative Site RECRUITING Sao Paulo SP 03102 Brazil Details
Novartis Investigative Site RECRUITING Sao Jose do Rio Preto 15090 000 Brazil Details
Novartis Investigative Site RECRUITING Sao Paulo 01255-000 Brazil Details
Novartis Investigative Site RECRUITING San Jose 95008 Costa Rica Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Heraklion Crete 71110 Greece Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Pokfulam Hong Kong Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Shatin HONGKONG Hong Kong Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Bhubaneshwar Orissa 751007 India Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Delhi 110 085 India Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Meldola FC 47014 Italy Details
Novartis Investigative Site COMPLETED Osaka-city Osaka 540-0006 Japan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Bunkyo ku Tokyo 113-8431 Japan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Bunkyo ku Tokyo 113-8677 Japan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Seoul 03080 Korea, Republic of Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Seoul 03722 Korea, Republic of Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING El Chouf LBN 1503201002 Lebanon Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Ashrafieh 166830 Lebanon Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Beirut 1107 2020 Lebanon Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING San Pedro Garza Garcia 66278 Mexico Details
Novartis Investigative Site RECRUITING Trujillo La Libertad 13011 Peru Details
Novartis Investigative Site RECRUITING San Borja Lima 41 Peru Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Gdansk 80 952 Poland Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Lisboa 1400-038 Portugal Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Loures 2674514 Portugal Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Porto 4200-072 Portugal Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Singapore 119228 Singapore Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Cape Town 7500 South Africa Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Johannesburg 2196 South Africa Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Pretoria 0002 South Africa Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Sant Joan Despi Barcelona 08970 Spain Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Taipei 10002 Taiwan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Taipei 11217 Taiwan Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Diyarbakir 21000 Turkey Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Izmir 35100 Turkey Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Kecioren Ankara 06010 Turkey Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Malatya 44280 Turkey Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Hanoi 100000 Vietnam Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field